Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001213900-23-096503)

Filing Details

Accession Number:: 0001213900-23-096503
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-12-18 16:15:24
Reporting Period:: 2023-12-15

Accepted Time:: 2023-12-18 16:15:24
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1690080	180 Life Sciences Corp.	ATNF	Pharmaceutical Preparations (2834)	813832378

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1832327	Marc Feldmann	3000 El Camino Real, Bldg. 4, Suite 200 Palo Alto CA 94306		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2023-12-15	25,000	$0.19	115,497	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

Effective on December 15, 2023, Prof. Sir Marc Feldmann, the Co-Executive Chairman of the Issuer, sold 25,000 shares of common stock of the Issuer to Dr. James N. Woody, the Chief Executive Officer of the Issuer, in a private transaction, for $4,720 or $0.188 per share, the closing sales price of the Issuer's common stock on such effective date.